Interviews

Featured in In-house

Neena Shenai, the Washington, DC-based chief global trade legal director at US-Irish medical device company Medtronic, tells GIR about the increased sanctions focus on the medical technology industry and what authorities could do to make compliance easier for the sector.

18 October 2021

Featured in In-house

Tapan Debnath, who joined ABB from Nokia in August, explains the company’s new approach to compliance and how it puts individual behaviour and responsibility front and centre.

12 October 2021

SNC-Lavalin’s compliance chief and monitor talk to GIR about the eight years the engineering company spent under the World Bank’s supervision. “Just when you feel like you have figured out the business, it changes,” said the monitor.

01 October 2021

Sweden is investigating alleged bribery by former Ericsson employees in Djibouti and two other countries, a local prosecutor told GIR in an interview.

12 May 2021

Featured in In-house

Max Lerner, who leads US bank State Street’s global sanctions and anti-bribery compliance efforts, tells GIR about the evolution of the sanctions compliance team, what keeps him up at night and the potential development that could significantly change his role.

16 April 2021

Ex-OFAC chief counsel Charlie Steele spoke to GIR about the future of US sanctions, his move back to private practice and why he chose not to join a law firm after leaving the government.

08 January 2021

Featured in Investigator's Guide to Brazil

Brazil’s former justice minister spoke to GIR about his time in government, the landmark Operation Car Wash probe and the country’s anti-corruption efforts.

04 December 2020

Wilson Sonsini partners Michael Sommer and Moe Fodeman tell GIR how they secured $138 million in restitution from a US hedge fund in a foreign bribery case.

19 November 2020

In an exclusive interview, the Netherlands’ top prosecutor at the EU’s nascent anti-corruption agency discussed lawyers’ potential apprehension in dealing with the new body and what their clients should know about EPPO’s powers.

06 November 2020

Featured in In-house

Novartis’s Shannon Thyme Klinger and Klaus Moosmayer talk to GIR about how the pharmaceutical company changed its approach to compliance in the midst of a series of government investigations.

05 October 2020